The analysis of second opinion cases of melanocytic tumours is the main activity of Léon Bérard Center.
We are very focused on this topic and have an extensive experience in this narrow field where the rarest variants of tumours are concentrated.
Léon Bérard Center has invested and developed many molecular tools to support morphological analysis, taking it to the next level of molecular pathology, in an integrative manner which notably allow to answer to specific questions regarding classification or histoprognostic criteria.
The Léon Bérard Center is at the cutting edge of diagnostic research with new antibodies and the most recent molecular techniques on site.